Skip to content

Memory Perception Assessment in Central/Non-central Nervous System Cancers

Prospective and Retrospective Memory Perception Assessment in Central/Non-central Nervous System Cancers

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03975959
Acronym
PROMESSE
Enrollment
426
Registered
2019-06-05
Start date
2019-05-10
Completion date
2024-10-31
Last updated
2026-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Glioblastoma, Glioma, Healthy

Keywords

PROMESSE, PROSPECTIVE MEMORY, RETROSPECTIVE MEMORY

Brief summary

Prospective memory (PM) is the ability to implement intended actions in the future. It allows maintaining and retrieving future plans, goals, and activities (i.e., remember to remember). PM is associated with most everyday memory problems . PM is crucial to correctly respond to all the social, occupational and working demands of everyday life, to perform many deferred health-related actions and is involved in therapeutic adherence . Indeed, PM errors are an important part of the aging memory complaints. The prevalence of self-reported PM failures is also significant among young adults, compared with self-reported retrospective memory (RM) failures .Yet, PM errors are major sources of frustration and embarrassment . In oncology, recently investigated the self-reported memory complaints in a 80 case-healthy-control study breast patients . Subjective memory complaints were assessed using the Prospective and Retrospective Memory Questionnaire . Results from the Paquet et al. study show that all participants (i.e., both patients and matched-controls) reported more PM than RM failures in daily-life (p\<.001). Breast cancer patients reported more RM and PM failures than controls. However, this group effect was no longer statistically significant when controlling for depression and fatigue. These findings are consistent with the view that memory complaints are closely associated with depression and cancer-related fatigue, and more generally with psychopathological variables .As underlined by Paquet et al. subjective memory complaints should be investigated because they refer to some aspects of the cancer experience that could potentially be linked to quality of life. Thus, it is important to explore psychopathological basis such as depression, anxiety and fatigue while investigating self-reported memory failures in cancer patients. Despites the importance of PM, there have been, to our knowledge, only few studies evaluating PM complaints or PM functioning in patients diagnosed with an intracerebral tumor (such as Diffuse Low-Grade Glioma- DLGG- or glioblastome- GB) or extra-cerebral tumor (such as breast cancer - BC). Therefore, the investigators thought it would be useful, as a first step, to conduct a study to explore and to manage the PM and RM subjective complaints in cancer patients compared to another chronic disease, such as HIV. In fine, these data will help to identify a new target for psychological management focused on either psychopathological or neuropsychological rehabilitation

Detailed description

Primary objective : This study will aim at determining the nature of subjective memory complaints (i.e., prospective or retrospective memory) in cancer patients with intra- cerebral tumors (Glioblastomas and Diffuse Low Grade Gliomas) and extra cerebral tumors (Breast cancer) compared with controls. The protocol administration will take about 20 minutes. It will be conducted by an experienced clinical neuropsychologist or clinical oncologist in each center during standard care. According to the results on the questionnaires and test, patients will be addressed and managed by a neuropsychologist, a clinical psychologist, psychiatrist or a speech therapist.

Interventions

OTHERQMRP questionnaire

a single consultation for test and questionnaires for a duration of 20 minutes

Sponsors

Institut du Cancer de Montpellier - Val d'Aurelle
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

The protocol administration will take about 20 minutes. It will be conducted by an experienced clinical neuropsychologist or clinical oncologist in each center during standard care. According to the results on the questionnaires and test, patients will be addressed and managed by a neuropsychologist, a clinical psychologist, psychiatrist or a speech therapist.

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

All the participants must fulfill all the following criteria to be eligible for study entry: * Be aged of 18 to 80 years old * Have a ECOG Performance Status ≤ 2 or a Karnofsky index ≥ 50 % * Have a satisfactory level of French * Have signed the informed consent Also, for the DLGG group, the patients must: * Have a histologically-proven diagnosis of DLGG (i.e., WHO grade II glioma) * Receive or have received a first oncological treatment after surgery (chemotherapy, radiation therapy…) Also, for the GB group, the patients must: \- Have a histologically-proven diagnosis of GB (i.e., WHO grade IV glioma). Also, for the breast cancer group, the patients must: \- Have a histologically-proven diagnosis of breast cancer diagnosed \< 2 years.

Exclusion criteria

Participants presenting with any of the following

Design outcomes

Primary

MeasureTime frameDescription
the nature of subjective memory complaints12 monthsscores from 8 to 40 of QMRP questionnaire

Secondary

MeasureTime frameDescription
the significant psychopathological correlates of the subjective PM and RM complaints12 monthsScores on the Hospital Anxiety Depression Scale from 0-21
the significant correlates between the subjective PM and RM complaints and the subjective fatigues12 monthsScores on the Multidimensional Fatigue Inventory-20
the significant correlates between the subjective PM and RM complaints12 monthsScores (from 0 to 30) on the Montreal Cognitive Assessment
the effect of disease on the subjective PM and RM complaints12 monthscomparison of clinical event between each group
the effect of cancer on the subjective PM and RM complaints12 monthsquestionnaire : frontal assessment battery compared between each groups

Countries

France

Contacts

STUDY_CHAIRGuerdoux Estelle, MD

ICM Co. Ltd.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 5, 2026